5-Amino-1MQ is a novel NNMT inhibitor that works at the epigenetic level to regulate cellular energy pathways
If the committee recommends inclusion, the FDA would still need to complete its review and rulemaking process before formally adding any of the substances to the 503A Bulks List
It raises IGF-1 levels (which can drive cell growth), can affect blood sugar regulation, and carries risks of promoting unwanted tissue proliferation
The Black Box warnings, full side effect list, and drug interaction details remain in the Safety Details section below
Furthermore, the amino acids contained in AOD 9604 are the same as those found in the naturally occurring growth hormone (hGH)
The compounds could potentially be combined, as their mechanisms do not overlap